tiprankstipranks
Advertisement
Advertisement
Fennec Showcases New PEDMARK Data at ASCO 2026
PremiumCompany AnnouncementsFennec Showcases New PEDMARK Data at ASCO 2026
3M ago
Fennec price target raised to $16 from $13 at H.C. Wainwright
Premium
The Fly
Fennec price target raised to $16 from $13 at H.C. Wainwright
3M ago
Fennec Pharmaceuticals Earnings Call Signals Robust Growth
Premium
Company Announcements
Fennec Pharmaceuticals Earnings Call Signals Robust Growth
3M ago
Fennec Pharmaceuticals: Buy Rating Reaffirmed on Accelerating PEDMARK Adoption and Multi-Region Growth Catalysts Through 2027
PremiumRatingsFennec Pharmaceuticals: Buy Rating Reaffirmed on Accelerating PEDMARK Adoption and Multi-Region Growth Catalysts Through 2027
5M ago
Fennec Pharmaceuticals Signals Costly Push Toward Growth
Premium
Company Announcements
Fennec Pharmaceuticals Signals Costly Push Toward Growth
5M ago
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds
Premium
Company Announcements
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds
5M ago
Fennec Secures PEDMARK Market Protection With Cipla Patent Litigation Settlement
PremiumCompany AnnouncementsFennec Secures PEDMARK Market Protection With Cipla Patent Litigation Settlement
5M ago
Fennec announces settlement agreement resolving Pedmark litigation
Premium
The Fly
Fennec announces settlement agreement resolving Pedmark litigation
5M ago
Buy Rating on Fennec Pharmaceuticals Driven by PEDMARK’s Long-Term Adoption Potential, Emerging Japan Upside, and Improving Profitability Supporting a $13 Target
Premium
Ratings
Buy Rating on Fennec Pharmaceuticals Driven by PEDMARK’s Long-Term Adoption Potential, Emerging Japan Upside, and Improving Profitability Supporting a $13 Target
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100